1.
Blecharczyk M, Jakimowicz A, KamiƄska ZZ, Malcher A, Mrozek M, Pacanowska-Trawnicka M, et al. Orforglipron as a Small-Molecule GLP-1 Receptor Agonist: A New Era of Incretin-Based Oral Therapy?. Qual Sport [Internet]. 2026 May 30 [cited 2026 Jun. 2];56:72512. Available from: https://apcz.umk.pl/QS/article/view/72512